
Results
3
3 companies
Kuros Biosciences
Market Cap: CHF 894.1m
Engages in the commercialization and development of biologic technologies for musculoskeletal care in the United States of America, the European Union, and internationally.
KURN
CHF 22.66
7D
14.4%
1Y
-24.6%
MindMaze Therapeutics Holding
Market Cap: CHF 30.4m
Operates as a commercial-stage biopharmaceutical and neurotechnology company in Asia, the United States, Switzerland, rest of Europe, and internationally.
MMTX
CHF 0.20
7D
26.1%
1Y
n/a
Cosmo
Market Cap: CHF 1.0b
A life sciences company, develops and manufactures pharmaceuticals and contracts for gastroenterology, dermatology, and health tech in Ireland and internationally.
COPN
CHF 60.00
7D
-5.7%
1Y
2.6%